´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦60ȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 |
|
´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦60ȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 ±³À°ÁÖÁ¦ : (¿ÀÇÁ¶óÀÎ) Á¦60ȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ À̸ÞÀÏ : ksh@koreanhypertension.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, °¡Á¤ÀÇÇаú, »ý¸®ÇÐ, ¾à¸®ÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À° Âü¼®¿¹»óÀÎ : 500¸í Áö¿ª : ´ëÀü±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 100,000¿ø ºñ°í *»çÀüµî·Ï: Á¤È¸¿ø(6¸¸¿ø), Á¤È¸¿ø ¿Ü(8¸¸¿ø), ±âŸ(4¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/º¸°ÇÀηÂ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), Àü°øÀÇ(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)*ÇöÀåµî·Ï: Á¤È¸¿ø(8¸¸¿ø), Á¤È¸¿ø ¿Ü(10¸¸¿ø), ±âŸ(5¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/º¸°ÇÀηÂ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), Àü°øÀÇ(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)
±³À°½Ã°£ 05¿ù 17ÀÏ Room B 08:50~09:10 °íÇ÷¾ÐÀÇ º´Àηп¡¼ ½ÉÀå ¹× Ç÷°üÀÇ ¿ªÇÒ Àüº´È(Ãæ³²ÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 09:10~09:30 °íÇ÷¾ÐÀÇ º´Àηп¡¼ ½ÅÀåÀÇ ¿ªÇÒ ±è±ÙÈ£(ÇѾçÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 09:30~09:50 °íÇ÷¾ÐÀÇ º´Àηп¡¼ ³»ºÐºñ°èÀÇ ¿ªÇÒ È«¾Æ¶÷(Àü³²ÀÇ´ë) Åä·Ð 05¿ù 17ÀÏ Room B 09:50~10:05 Åä·Ð ±èÁöÀÎ, ¹èÀºÈñ, ¼»óÇå, ÃÖ´ëÀº(°è¸íÀÇ´ë, Àü³²ÀÇ´ë, Àü³²ÀÇ´ë, Ãæ³²ÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 10:15~10:30 ¼Ò¾Æ°íÇ÷¾ÐÀÇ Áø´Ü°ú Ç÷¾Ð ÃøÁ¤ ±è¼ºÇý(Â÷ÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 10:30~10:45 ¼Ò¾Æ°íÇ÷¾Ð Áø´ÜÀ» À§ÇÑ Ãß°¡ °Ë»çµé°ú Ç¥Àû ±â°ü ¼Õ»ó¿¡ ´ëÇÑ Æò°¡ ¿À°æÁø(¼¿ïÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 10:45~11:00 ¼Ò¾Æ°íÇ÷¾ÐÀÇ Ä¡·á; ºñ¾à¹°Àû/¾à¹°Àû Ä¡·á Á¤¼öÀÎ(¾ÆÁÖÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 11:00~11:15 Ưº°ÇÑ »óȲ¿¡¼ÀÇ ¼Ò¾Æ°íÇ÷¾ÐÀÇ Ä¡·á; ±Þ¼º ÁßÁõ °íÇ÷¾Ð, ÀúÇ×¼º °íÇ÷¾Ð, ¾Ç¼º °íÇ÷¾Ð, Àå±â ÀÌ½Ä È¯ÀÚ °íÇ÷¾ÐÄ¡·á ÀÌ¿¬Èñ(°¡Å縯ÀÇ´ë) Åä·Ð 05¿ù 17ÀÏ Room B 11:15~11:30 Åä·Ð ¹ÚÀ¯Áø, À¯°æÈñ, ÀÌ»óÀ±, ÀÌÁ¤¿ø(°í·ÁÀÇ´ë, šœÃµÇâÀÇ´ë, ¼¿ïÀÇ´ë, ÀÌÈÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room A 11:40~12:10 º¸°ÇÀηÂ, Á¤Ã¥ÀÔ¾ÈÀÚ, ´ÙÇÐÁ¦, ¾ð·ÐÀÌ ÇÔ²²ÇÏ´Â °íÇ÷¾Ð °ü¸® ¹æ¾È ¸¶·Ã ¹ÚÇö¿µ(±¹¸³º¸°Ç¿¬±¸¿ø) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 12:20~12:40 Importance of 24h BP Control for Reducing CVD Risk; The Role of Azilsartan ±èÁöÇö(µ¿±¹ÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 12:40~13:00 Intensive Treatment Strategy in Hypertension ¹ÚÁøÁÖ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 13:20~13:35 ºÎ½Å Á¾¾ç°ú °íÇ÷¾Ð I (¾Ëµµ½ºÅ×·ÐÁõ) ÀÓÁ¤¼ö(¿¬¼¼¿¬¼¼¿øÁÖÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 13:35~13:50 ºÎ½Å Á¾¾ç°ú °íÇ÷¾Ð II (Pheochromocytoma) ·ù¿ÁÇö(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 13:50~14:05 Ä®½·°ú °íÇ÷¾Ð, ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ À̽ÃÈÆ(°¡ÃµÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 14:05~14:20 ½ºÅ×·ÎÀ̵å¿Í °íÇ÷¾Ð, Äí½Ì ÁõÈıº ¹Ú½Â½Å(¼¿ïÀÇ´ë) Åä·Ð 05¿ù 17ÀÏ Room B 14:20~14:35 Åä·Ð ±è¿øÁø, Àü°æÇö, À̹ÎÈ£(Â÷ÀÇ°úÇдëÇб³, Àϻ꺴¿ø, ¼øõÇâÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 14:45~15:00 °íÇ÷¾Ð ȯÀÚ¿¡°Ô "°í°µµ °£ÇæÀû ¿îµ¿" ±ÇÀåÇصµ µÉ±î¿ä? ±è¿µÁÖ(¼º½Å¿©ÀÚ´ëÇб³) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 15:00~15:15 ¹Ì¶óŬ ¸ð´× ¿îµ¿, °íÇ÷¾Ð ȯÀÚµµ ±¦ÂúÀ»±î¿ä? À±Àº¼±(Çѱ¹¹æ¼ÛÅë½Å´ëÇб³) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 15:15~15:30 Ç÷¾Ð °ü¸®¸¦ À§ÇÑ »õ·Î¿î ¿îµ¿: Beyond Aerobic Exercise ÃÖÈ£°æ(Çѱ¹½ºÆ÷Ã÷Á¤Ã¥°úÇпø) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 15:30~15:45 ¿Ü·¡¿¡¼ °íÇ÷¾Ð ȯÀÚÀÇ ½ÅüȰµ¿ ÃËÁøÀ» À§ÇÑ »ó´ã±â¹ý ±èÀºÁö(°æ±âµµ °íÇ÷¾Ð¡¤´ç´¢º´ ±¤¿ª±³À°¼¾ÅÍ) Åä·Ð 05¿ù 17ÀÏ Room B 15:45~16:00 Åä·Ð ¹Ú¼öÇö, ÀÌÁ¾¿µ, Á¶Áø°æ, ÇÑÅ°æ(Çѱ¹½ºÆ÷Ã÷Á¤Ã¥°úÇпø, ¼º±Õ°üÀÇ´ë, ¼º±Õ°ü´ëÇб³, ±¹¸³¾Èµ¿´ëÇб³) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 16:10~16:25 °íÇ÷¾Ð ȯÀÚ °ü¸®¸¦ À§ÇÑ ½º¸¶Æ® ±â±â ÀÌÇØ¿µ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 16:25~16:40 °íÇ÷¾Ð ¿¬±¸¿¡¼ÀÇ ÀΰøÁö´É°ú ºòµ¥ÀÌÅÍ È°¿ë Àü±âÇö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 16:40~16:55 µðÁöÅÐ Çコ Äɾî¿Í °íÇ÷¾Ð Ä¡·á ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) ±³À°½Ã°£ 05¿ù 17ÀÏ Room B 16:55~17:10 ÀÓ»ó Áø·á¿¡¼ÀÇ LLM(Large Language Model)ÀÇ È°¿ë À¯¼±Çü(¸ÞµðÇãºê) Åä·Ð 05¿ù 17ÀÏ Room B 17:10~17:25 Åä·Ð ½Åµ¿È£, À¯½ÂÂù, Á¶ÁØȯ(¿¬¼¼ÀÇ´ë, ¿¬¼¼ÀÇ´ë, Áß¾ÓÀÇ´ë)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 944 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 927 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 777 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 956 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 810 , ´ñ±Û¼ö : 0 |